Ruibo (Taizhou) Pharmaceutical Co., Ltd.‘s announced a placement of common shares for gross proceeds of CNY 600,000,000 on January 20, 2023. The transaction will include participation from returning investor, Zhejiang Jiuzhou Pharmaceutical Co., Ltd. In the transaction, CNY 50,000,000 will go to registered capital, and the company's registered capital will increase from CNY 100,000,000 to CNY 150,000,000. The transaction has been approved in the 26th meeting of Zhejiang Jiuzhou Pharmaceutical Co., Ltd's 7th directorate and the 20th meeting of the 7th supervisory board and does not need the shareholders' approval.